Biggest News Aggregation in the World
📰 Frozen Plasma News

Frozen Plasma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Frozen Plasma. Real-time updates on events, politics, business and more.

Global Hemostasis Products Industry Estimated to Surpass US$2.65 Billion by 2033, at a CAGR of 5.3%

Global Hemostasis Products IndustryThe Global Hemostasis Products Industry is gearing up for substantial expansion, with an estimated valuation of US$1.58 billion in 2023, projected to surge past US$2.65 billion by 2033. This remarkable growth trajectory is anticipated to unfold at a steady Compound Annual Growth Ra...
United States New York B Braun Melsungen Becton Dickinson Consumer Technology Baxter Healthcare Corporation

Global Fibrinogen Concentrate Market to 2030: Increasing use of Fibrinogen Concentrates in Patients for Treatment of Bleeding and Congenital Deficiencies Drives Growth

/PRNewswire/ -- The "Fibrinogen Concentrate Market Size, Share, Trends, By Type, By Application, and By Region Forecast to 2030" report has been added to...
Laura Wood Jiangxi Boya Bio Harbin Pacific Biopharmaceutical Co E St Office Hours Call Green Cross Office Hours Call

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Hemostasis Products Market is expected to reach a valuation of US$ 2638 Million by 2032, at a CAGR o

The global Hemostasis Products Market is expected to be worth US$ 1580 million in 2022. The market is expected to be worth US$ 2638 million between 2022 and 2032, at a CAGR of 5.3%. The rising prevalence of chronic blood disorders can be attributed to the market’s expansion.High-level technological advancements, str...
United States New York B Braun Melsungen Greater New York Chamber Becton Dickinson Baxter International Inc

Cureus | Intraparenchymal Hematoma With Significant Mass Effect Treated With Factor Eight Inhibitor Bypass Activity

The authors present the case of an 80-year-old female with myelodysplastic syndrome treated with chemotherapy and apixaban, a direct oral anticoagulant who suffered an intracranial hemorrhage. She presented to the emergency department with altered mental status and was found to have a large intraparenchymal hematoma with a significant mass effect. Our patient was given FEIBA (Factor Eight Inhibitor Bypass Activity) to reverse the hemorrhage. Anticoagulant-related bleeding reversal strategies ...
Aspartate Transaminase International Normalized Ratio Factor Eight Inhibitor Bypass Activity Prothrombin Complex Concentrate Frozen Plasma
Source: cureus.com

Blood Plasma Derivatives for IVD Market Clinical Research Report 2021 – 2025: Biotest AG, CSL Limited (Australia), Kedrion S.p.A – KSU

Blood Plasma Derivatives for IVD Market Report Forecast 2021 – 2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Blood Plasma Derivatives for IVD market and offers a clear assessment of the projected market fluctuations during the forecast pe...
United Kingdom South Africa Saudi Arabia Research On Blood Plasma Derivatives Bain Capital Baxter International Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science